A REVIEW OF WHO MAKES THE DIABETES DRUG COPYRIGHT

Novo Nordisk’s Wegovy and copyright, both equally run by semaglutide, have revolutionized obesity treatment method by means of unparalleled weight loss results.In Oct 2024, Novo Nordisk printed a study on scientific journal Mother nature about a novel glucose-sensitive insulin NNC2215 that can lower the risk of hypoglycemia in animal types.[sixty